Vavra N, Sevelda P, Barrada M, Kucera H
Ordinariat für gynäkologische Strahlentherapie der Universität Wien.
Geburtshilfe Frauenheilkd. 1989 Sep;49(9):793-6. doi: 10.1055/s-2008-1036087.
Of 1484 patients with invasive carcinoma of the cervix who underwent primary radiotherapy, 65 (4.4%) were found to have adenocarcinoma. These adenocarcinoma patients were matched with squamous cell carcinoma patients on the basis of age, stage and 5-year survival rates. In 703 patients with squamous cell carcinoma, there was no difference in age and stage compared to those patients, who had an adenocarcinoma of the cervix. The cumulative 5-year survival rates for 65 patients in the adenocarcinoma group (30.7%) were not significantly different, but were remarkably lower with the squamous cell control subjects (42.7%). Only the 5-year survival results for patients with FIGO stage 2 disease were significantly less than those of our control group. For patients with stage 3 disease there were nearly the same results (30%) in both groups. Our results underline the importance of radiotherapy for the treatment of inoperable patients with invasive adenocarcinoma of the uterine cervix.
在1484例接受原发性放射治疗的宫颈浸润癌患者中,有65例(4.4%)被发现患有腺癌。这些腺癌患者在年龄、分期和5年生存率的基础上与鳞状细胞癌患者进行匹配。在703例鳞状细胞癌患者中,与患有宫颈腺癌的患者相比,年龄和分期没有差异。腺癌组65例患者的累积5年生存率(30.7%)没有显著差异,但明显低于鳞状细胞癌对照组(42.7%)。只有国际妇产科联盟(FIGO)2期疾病患者的5年生存结果显著低于我们的对照组。对于3期疾病患者,两组的结果几乎相同(30%)。我们的结果强调了放射治疗对于治疗无法手术的宫颈浸润性腺癌患者的重要性。